NL-OMON43870已完成不适用
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (PRESANO trial) - PRESANO trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 215
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Planned to undergo neoadjuvant chemoradiotherapy according to CROSS, followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma
- •- Age >= 18
- •- Written, voluntary informed consent
排除标准
- •- Dementia or altered mental status prohibiting the understanding and giving of informed consent
研究者
相似试验
招募中
不适用
Response evaluation after neoadjuvant chemotherapy for muscle invasive bladder cancerNL-OMON25664ot applicable180
已完成
不适用
The accuracy of detecting residual disease following neo-adjuvant chemotherapy in patients with muscle-invasive bladder cancerMuscle invasive urothelial cell carcinoma of the bladder10004994Bladder cancerNL-OMON50035Vrije Universiteit Medisch Centrum180
已完成
不适用
Pre-Surgery If Needed for Oesophageal CancerEsophageal CancerNCT03937362Shanghai Chest Hospital200
尚未招募
不适用
Retrospective study of the diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectable pancareatic cancer after neoadjuvant S-1 and concurrent radiotherapyBorderline resectable pancreatic cancerJPRN-UMIN000029166ational Cancer Centor Japan53
已完成
Unknown
Diagnostic Accuracy and Prognostic Value of Relative Apical Sparing in Cardiac Amyloidosis: A Systematic Review and Meta-Analysiscardiac amyloidosisJPRN-UMIN000053051Hospital of University of Occupational and Environmental Health, School of Medicine1,000